# Teriparatide for Fracture Repair in Humans

> **NCT02091492** · PHASE3 · WITHDRAWN · sponsor: **Medical University of Vienna**

## Conditions studied

- Osteoporosis, Age-Related
- Humeral Fractures

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02091492
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participants
- **Last updated:** 2015-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02091492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02091492, "Teriparatide for Fracture Repair in Humans". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02091492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*